This Article Full Text Full Text (PDF) All Versions of this Article: 17/1/56    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhou, S. Articles by Gazit, D. Search for Related Content PubMed PubMed Citation Articles by Zhou, S. Articles by Gazit, D.

Estrogens Activate Bone Morphogenetic Protein-2 Gene Transcription in Mouse Mesenchymal Stem Cells

Skeletal Biotechnology Laboratory (S.Z., G.T., D.G.), Hebrew University-Hadassah Medical Center, Jerusalem 91120, Israel; University of California-San Francisco (D.C.L.), San Francisco, California 94143; University of Texas Health Science Center (S.E.H.), San Antonio, Texas 78229; and Women’s Health Research Institute (B.S.K., P.V.N.B.), Wyeth Research, Collegeville, Pennsylvania 19426

Address all correspondence and requests for reprints to: Dan Gazit, D.M.D., Ph.D., Molecular Pathology Laboratory, Hebrew University-Hadassah Medical and Gene Therapy Center, P. O. Box 12272, Jerusalem 91120, Israel. E-mail: dgaz{at}cc.huji.ac.il.

Estrogens exert their physiological effects on target tissues by interacting with the estrogen receptors, ER and ERß. Estrogen replacement is one the most common and effective strategies used to prevent osteoporosis in postmenopausal women. Whereas it was thought that estrogens work exclusively by inhibiting bone resorption, our previous results show that 17ß-estradiol (E2) increases mouse bone morphogenetic protein (BMP)-2 mRNA, suggesting that estrogens may also enhance bone formation. In this study, we used quantitative real-time RT-PCR analysis to demonstrate that estrogens increase BMP-2 mRNA in mouse mesenchymal stem cells. The selective ER modulators, tamoxifen, raloxifene, and ICI-182,780 (ICI), failed to enhance BMP-2 mRNA, whereas ICI inhibited E2 stimulation of expression. To investigate if estrogens increase BMP-2 expression by transcriptional mechanisms and if the response is mediated by ER and/or ERß, we studied the effects of estrogens on BMP-2 promoter activity in transient transfected C3H10T1/2 cells. E2 produced a dose-dependent induction of the mouse -2712 BMP-2 promoter activity in cells cotransfected with ER and ERß. At a dose of 10 nM E2, ER induced mouse BMP-2 promoter activity 9-fold, whereas a 3-fold increase was observed in cells cotransfected with ERß. Tamoxifen and raloxifene were weak activators of the mouse BMP-2 promoter via ER, but not via ERß. ICI blocked the activation of BMP-2 promoter activity by E2 acting via both ER and ERß, indicating that mouse BMP-2 promoter activation is ER dependent. In contrast to E2 and selective ER modulators, the phytoestrogen, genistein was more effective at activating the mouse BMP-2 promoter with ERß, compared with ER. Using a deletion series of the BMP-2 promoter, we determined that AP-1 or Sp1 sites are not required for E2 activation. A mutation in a sequence at -415 to -402 (5'-GGGCCActcTGACCC-3') that resembles the classical estrogen-responsive element abolished the activation of the BMP-2 promoter in response to E2. Our studies demonstrate that E2 activation of mouse BMP-2 gene transcription requires ER or ERß acting via a variant estrogen-responsive element binding site in the promoter, with ER being the more efficacious regulator. Estrogenic compounds may enhance bone formation by increasing the transcription of the BMP-2 gene.

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα  |  ERβ

Ligands:   17β-Estradiol  |  Raloxifene

This article has been cited by other articles:

				R. H. Straub The Complex Role of Estrogens in Inflammation Endocr. Rev., August 1, 2007; 28(5): 521 - 574. [Abstract] [Full Text] [PDF]

				J.-L. Su, C.-Y. Yang, M. Zhao, M.-L. Kuo, and M.-L. Yen Forkhead Proteins Are Critical for Bone Morphogenetic Protein-2 Regulation and Anti-tumor Activity of Resveratrol J. Biol. Chem., July 6, 2007; 282(27): 19385 - 19398. [Abstract] [Full Text] [PDF]

				N. L. Cho, S. H. Javid, A. M. Carothers, M. Redston, and M. M. Bertagnolli Estrogen Receptors {alpha} and {beta} Are Inhibitory Modifiers of Apc-Dependent Tumorigenesis in the Proximal Colon of Min/+ Mice Cancer Res., March 1, 2007; 67(5): 2366 - 2372. [Abstract] [Full Text] [PDF]

				N. Fukui, Y. Ikeda, T. Ohnuki, A. Hikita, S. Tanaka, S. Yamane, R. Suzuki, L. J. Sandell, and T. Ochi Pro-inflammatory Cytokine Tumor Necrosis Factor-{alpha} Induces Bone Morphogenetic Protein-2 in Chondrocytes via mRNA Stabilization and Transcriptional Up-regulation J. Biol. Chem., September 15, 2006; 281(37): 27229 - 27241. [Abstract] [Full Text] [PDF]

				I. Shur, R. Solomon, and D. Benayahu Dynamic Interactions of Chromatin-Related Mesenchymal Modulator, a Chromodomain Helicase-DNA-Binding Protein, with Promoters in Osteoprogenitors. Stem Cells, May 1, 2006; 24(5): 1288 - 1293. [Abstract] [Full Text] [PDF]

				C. Morris, J. Thorpe, L. Ambrosio, and M. Santin The Soybean Isoflavone Genistein Induces Differentiation of MG63 Human Osteosarcoma Osteoblasts J. Nutr., May 1, 2006; 136(5): 1166 - 1170. [Abstract] [Full Text] [PDF]

				G. R Mundy Nutritional modulators of bone remodeling during aging Am. J. Clinical Nutrition, February 1, 2006; 83(2): 427S - 430S. [Abstract] [Full Text] [PDF]

				D. T. Fritz, D. Liu, J. Xu, S. Jiang, and M. B. Rogers Conservation of Bmp2 Post-transcriptional Regulatory Mechanisms J. Biol. Chem., November 19, 2004; 279(47): 48950 - 48958. [Abstract] [Full Text] [PDF]

				K. L. Abrams, J. Xu, C. Nativelle-Serpentini, S. Dabirshahsahebi, and M. B. Rogers An Evolutionary and Molecular Analysis of Bmp2 Expression J. Biol. Chem., April 16, 2004; 279(16): 15916 - 15928. [Abstract] [Full Text] [PDF]